XK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.957600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.718200E-02
Normal-vs-Stage2
1.031040E-04
Normal-vs-Stage3
6.901000E-01
Normal-vs-Stage4
1.363760E-01
Stage1-vs-Stage2
9.417400E-01
Stage1-vs-Stage3
7.408000E-02
Stage1-vs-Stage4
8.938000E-01
Stage2-vs-Stage3
4.064200E-03
Stage2-vs-Stage4
8.563400E-01
Stage3-vs-Stage4
1.126160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.167000E-04
Normal-vs-AfricanAmerican
7.939900E-02
Normal-vs-Asian
2.174200E-01
Caucasian-vs-AfricanAmerican
5.003400E-01
Caucasian-vs-Asian
8.213600E-01
AfricanAmerican-vs-Asian
4.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.85229999996695E-06
Normal-vs-Female
2.343200E-01
Male-vs-Female
1.841630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.139850E-01
Normal-vs-Age(41-60Yrs)
9.87919999999587E-05
Normal-vs-Age(61-80Yrs)
9.94640000000491E-05
Normal-vs-Age(81-100Yrs)
1.812230E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.027000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.294800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.462000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.223200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.513200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.184970E-03
Normal-vs-Daily Drinker
4.982600E-03
Normal-vs-Weekly Drinker
4.037700E-02
Normal-vs-Occasional Drinker
1.451200E-01
Normal-vs-Social Drinker
3.096300E-02
Non Drinker-vs-Daily Drinker
8.871600E-01
Non Drinker-vs-Weekly Drinker
8.774000E-01
Non Drinker-vs-Occasional Drinker
8.300400E-01
Non Drinker-vs-Social Drinker
6.394800E-01
Daily Drinker-vs-Weekly Drinker
8.017000E-01
Daily Drinker-vs-Occasional Drinker
7.393800E-01
Daily Drinker-vs-Social Drinker
5.859800E-01
Weekly Drinker-vs-Occasional Drinker
9.821200E-01
Weekly Drinker-vs-Social Drinker
7.997400E-01
Occasional Drinker-vs-Social Drinker
7.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.603800E-01
Normal-vs-Grade 2
1.756760E-01
Normal-vs-Grade 3
2.060800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.794200E-01
Grade 1-vs-Grade 3
2.090000E-01
Grade 1-vs-Grade 4
2.603800E-01
Grade 2-vs-Grade 3
6.223000E-01
Grade 2-vs-Grade 4
1.756760E-01
Grade 3-vs-Grade 4
2.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.243100E-04
Normal-vs-NonDiabetic
1.557980E-04
Diabetic-vs-NonDiabetic
6.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.041700E-02
Normal-vs-NoPancreatitis
1.955530E-04
Pancreatitis-vs-NoPancreatitis
5.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.006900E-04
Normal-vs-N1
1.246410E-04
N0-vs-N1
8.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.1414000000709E-07
Normal-vs-TP53-NonMutant
1.21259999996681E-06
TP53-Mutant-vs-TP53-NonMutant
4.731800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
